Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025

Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025

Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish third quarter 2025 financial results on Tuesday, November 4, 2025, after U.S. market close.

About Standard BioTools Inc.

Standard BioTools Inc. (Nasdaq: LAB), has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop better medicines faster. As a leading solutions provider, the company provides reliable and repeatable insights in health and disease using its proprietary SomaScan, mass cytometry and microfluidics technologies, which help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology and immunotherapy. Learn more at standardbio.com or connect with us on X, Facebook ® , LinkedIn, and YouTube™.

Limited Use Label License and other terms may apply: standardbio.com/legal/salesterms .
Patent and License Information: standardbio.com/legal/notices .
©2025 Standard BioTools Inc. All rights reserved.

Standard BioTools products are provided for Research Use Only. Not for use in diagnostic procedures.

Investor Contact:
ir@standardbio.com


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

Standard BioToolsLABNGS:LABbiotech investing
LAB
The Conversation (0)
Pinnacle Provides First Results from Underground Drilling Program at El Potrero; Samples up to 59.2 g/t Au and 424 g/t Ag with Visible Gold

Pinnacle Provides First Results from Underground Drilling Program at El Potrero; Samples up to 59.2 g/t Au and 424 g/t Ag with Visible Gold

(TheNewswire) VANCOUVER, BRITISH COLUMBIA, August 18, 2026 TheNewswire - (TSXV: PINN,OTC:PSGCF, OTCQB: PSGCF, Frankfurt: P9J) Pinnacle Silver and Gold Corp. ("Pinnacle" or the "Company") is pleased to provide an update on the ongoing underground drilling program at the Potrero gold-silver... Keep Reading...
American Eagle Drills One Kilometre of Copper-Gold Mineralization from Surface at NAK: 1,001 Metres of 0.46% CuEq, Including 218 Metres of 1.01% CuEq

American Eagle Drills One Kilometre of Copper-Gold Mineralization from Surface at NAK: 1,001 Metres of 0.46% CuEq, Including 218 Metres of 1.01% CuEq

Highlights: NAK26-87 intersected 1,001 metres of 0.46% copper equivalent (CuEq) starting at surface, including 218 metres of 1.01% CuEq, a full kilometre of continuous copper-gold mineralization and the longest mineralized intercept ever drilled at NAK. Kilometre-long intercepts of copper and... Keep Reading...
Goldgroup Reports Selected Drill Results Highlighting Growth Potential at Don David

Goldgroup Reports Selected Drill Results Highlighting Growth Potential at Don David

Drilling Supports Production Replacement, Defines Mineralized Extensions and Advances Newly Identified TargetsGoldgroup Mining Inc. (TSXV: GORO) (NYSE American: GORO) (FSE: 55G) ("Goldgroup" or the "Company") is pleased to report selected drill results from its Don David Gold Mine ("DDGM")... Keep Reading...
Goldgroup Reports Selected Drill Results Highlighting Growth Potential at Don David

Goldgroup Reports Selected Drill Results Highlighting Growth Potential at Don David

Drilling Supports Production Replacement, Defines Mineralized Extensions and Advances Newly Identified TargetsGoldgroup Mining Inc. (TSXV: GORO) (NYSE American: GORO) (FSE: 55G) ("Goldgroup" or the "Company") is pleased to report selected drill results from its Don David Gold Mine ("DDGM")... Keep Reading...
AuKing Mining (ASX:AKN)

First Tundulu Diamond Hole Intersects Carbonatites to End of Hole (510m)

AuKing Mining Limited (ASX: AKN) (“AuKing” or “the Company”) is pleased to provide a further progress report on its drilling activities at the Tundulu Rare Earth Project in southern Malawi, having now commenced the large diamond drilling phase of the program.Highlights Excellent progress... Keep Reading...
Lexaria Enters a Material Transfer Agreement With PegBio

Lexaria Enters a Material Transfer Agreement With PegBio

KELOWNA, BC / ACCESS Newswire / August 13, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that it has entered into a Material Transfer Agreement ("MTA") with Pegbio Co., Ltd ("PegBio") to investigate Lexaria's... Keep Reading...
Person in blue scrubs interacts with a digital interface featuring graphs and medical icons.

Biotech and Pharma Market Trends: Q2 2026 Review and Forecast

Biotech is starting to edge back into focus as investors reassess the durability of the artificial intelligence (AI) trade and look for sectors where AI is producing tangible operational gains. “There are concerns that we’re in an AI bubble, and I think money is starting to go from companies... Keep Reading...
Row of test tubes and pipette with chemical droplet chemical coming from it.

Top 5 Small-cap Biotech Stocks in 2026

The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) has climbed back to multi-year highs in 2026, underscoring renewed strength in the biotech sector despite broader market volatility. As of July 7, the index stood at 6,856.74, up over 20 percent year-to-date. The rise shows that investors are... Keep Reading...
Lexaria Updates Business Development

Lexaria Updates Business Development

(TheNewswire) Kelowna, British Columbia July 6, 2026 TheNewswire Lexaria Bioscience Corp. (Nasdaq: LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to have experienced many positive meetings with potential pharmaceutical partners and collaborators at... Keep Reading...
Lexaria Updates Business Development

Lexaria Updates Business Development

KELOWNA, BC / ACCESS Newswire / July 6, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to have experienced many positive meetings with potential pharmaceutical partners and collaborators at the 2026 BIO... Keep Reading...
Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule

Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule

KELOWNA, BC / ACCESS Newswire / June 25, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that dosing began on schedule on June 14th with Human Pilot Study #7 (GLP-1-H26-7) that is evaluating two oral... Keep Reading...

Latest News

More News

Interactive Chart

Latest Press Releases

Great Western Mining Corporation plc Announces Holding in Company

AmeriTrust Auto Advances End-to-End Lease Remarketing Strategy

IMARC 2026 puts strategy into action as global mining leaders commit to Australia’s biggest mining conference

Great Western Mining Corporation PLC Announces Holding in Company

Related News

base metals investing

Great Western Mining Corporation plc Announces Holding in Company

lithium investing

Lithium Chile Challenges Canadian Review of China Deal

copper investing

Lundin Cuts Copper Target After Another Storm Hits Chile

precious metals investing

IMARC 2026 puts strategy into action as global mining leaders commit to Australia’s biggest mining conference

base metals investing

Great Western Mining Corporation PLC Announces Holding in Company

oil and gas investing

Angkor Resources Drills Initial Program at Andong Bor Copper-Gold Target, Cambodia

battery metals investing

VanadiumCorp Completes Soil Geochemical Survey at its Lac Laura Gold-Copper Property; 314 Samples Submitted to AGAT Laboratories for Analysis